• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov25
Olema Pharmaceuticals Director Exercises Options and Makes Gifts of Stock
23:06
Nov22
LifeSci Capital analyst reiterates buy rating on Olema Pharmaceuticals
15:36
Nov18
H.C. Wainwright Raises Olema Pharmaceuticals Price Target to $36
16:38
Nov13
Sam Slutsky Maintains Buy Rating for Olema Pharmaceuticals
21:27
Nov11
Olema Pharmaceuticals released FY2025 Q3 earnings on November 10 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.4924 (forecast USD -0.4703)
04:00
Olema Pharmaceuticals released FY2025 9 Months Earnings on November 10 (EST), with actual revenue of USD 0 and actual EPS of USD -1.3602
04:00

Schedules & Filings

Schedules
Filings
Nov10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -42.22 M, EPS -0.4924

Aug11
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -43.78 M, EPS -0.5121

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -30.39 M, EPS -0.3557

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
25.440
+276.44%
+18.682
SMX
331.980
+135.45%
+190.980
WHLR
6.410
+97.84%
+3.170
GURE
8.190
+72.78%
+3.450
DBRG
14.120
+45.27%
+4.400
TORO
5.800
+40.44%
+1.670
TDIC
0.3937
+40.21%
+0.113
LICN
4.070
+38.91%
+1.140
SPHL
4.530
+36.04%
+1.200
ALMS
11.120
+33.98%
+2.820
View More